Urinary Nitrite/Nitrate Concentrations and Total Antioxidant Capacity in Patients with Chronic Hepatitis C in Therapy with Interferon and Ribavirin
暂无分享,去创建一个
R. Corrocher | P. Perfetti | L. Cuzzolin | G. Gabrielli | G. Benoni | M. Pasino | A. Stanzial | A. Stanzial
[1] D. Sorbi,et al. Nitric Oxide and Chronic HCV and HIV Infections , 2001, Digestive Diseases and Sciences.
[2] K. Shiraki,et al. Increased plasma nitrate and nitrite concentrations in patients with hepatitis C virus infection. , 2001, Journal of hepatology.
[3] M. Colasanti,et al. The dual personality of NO. , 2000, Trends in pharmacological sciences.
[4] P. Hayes,et al. Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma , 2000, European journal of gastroenterology & hepatology.
[5] E. Brunt,et al. Grading and staging the histopathological lesions of chronic hepatitis: The Knodell histology activity index and beyond , 2000, Hepatology.
[6] C. J. Chen,et al. Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. , 1999, American journal of epidemiology.
[7] G. Filice,et al. Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings , 1999, American Journal of Gastroenterology.
[8] D. Holben,et al. The diverse role of selenium within selenoproteins: a review. , 1999, Journal of the American Dietetic Association.
[9] G. Brocco,et al. A microplate-based colorimetric assay of the total peroxyl radical trapping capability of human plasma. , 1999, Analytical biochemistry.
[10] M. Ozcan,et al. Increased serum nitrite and nitrate concentrations in chronic hepatitis. , 1998, Journal of hepatology.
[11] J. Prieto,et al. Superoxide dismutase in patients with chronic hepatitis C virus infection. , 1998, Free radical biology & medicine.
[12] D. Early,et al. Plasma selenium in patients with cirrhosis , 1998, Hepatology.
[13] O. Olivieri,et al. Erythrocyte membrane lipids and serum selenium in post-viral and alcoholic cirrhosis. , 1998, Clinica chimica acta; international journal of clinical chemistry.
[14] L. Grayson,et al. The Total Antioxidant Capacity of Human Serum Measured Using Enhanced Chemiluminescence is Almost Completely Accounted for by Urate , 1997, Annals of clinical biochemistry.
[15] A. Masumoto,et al. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma. , 1997, The American journal of gastroenterology.
[16] A. Barnett,et al. Antioxidant status in patients with uncomplicated insulin‐dependent and non‐insulin‐dependent diabetes mellitus , 1997, European journal of clinical investigation.
[17] V. Paradis,et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. , 1997, Journal of clinical pathology.
[18] T. Pirttilä,et al. Unidentified antioxidant defences of human plasma in immobilized patients: a possible relation to basic metabolic rate. , 1997, Free radical research.
[19] J. Bartolomé,et al. Decreased nitric oxide production in chronic viral hepatitis B and C , 1997, Journal of medical virology.
[20] K. Kröncke,et al. Nitric oxide: cytotoxicity versus cytoprotection--how, why, when, and where? , 1997, Nitric oxide : biology and chemistry.
[21] M. Copland,et al. Basal nitric oxide synthesis in essential hypertension , 1997, The Lancet.
[22] B. Halliwell,et al. Protection Against Peroxynitrite-Dependent Tyrosine Nitration and α1-Antiproteinase Inactivation by Ascorbic Acid. A Comparison with other Biological Antioxidants , 1996 .
[23] J. Beckman. Oxidative damage and tyrosine nitration from peroxynitrite. , 1996, Chemical research in toxicology.
[24] E. Larrea,et al. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C , 1996 .
[25] A. Casadevall,et al. Immune complexes increase nitric oxide production by interferon‐γ‐stimulated murine macrophage‐like J774.16 cells , 1995, Journal of leukocyte biology.
[26] V. Carreño,et al. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-α , 1994, Digestive Diseases and Sciences.
[27] C. Lowenstein,et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. V. Hunt,et al. Ascorbic acid oxidation: A potential cause of the elevated severity of atherosclerosis in diabetes mellitus? , 1992, FEBS letters.
[29] S. Tannenbaum,et al. DNA damage and mutation in human cells exposed to nitric oxide in vitro. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[30] S. Dimauro,et al. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. , 1991, American journal of human genetics.
[31] K. Yoshioka,et al. Tumor necrosis factor α production by peripheral blood mononuclear cells of patients with chronic liver disease , 1989 .
[32] K. Ingold,et al. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. , 1987, Biochimica et biophysica acta.
[33] G. Mengozzi,et al. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins. , 1997, Journal of hepatology.
[34] M. Koziel. Immunology of viral hepatitis. , 1996, The American journal of medicine.
[35] D. V. van Thiel,et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. , 1996, Free radical biology & medicine.
[36] V. Carreño,et al. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha. , 1994, Digestive diseases and sciences.
[37] S. Snyder,et al. Nitric oxide: a physiologic messenger molecule. , 1994, Annual review of biochemistry.